COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday Japan's health regulator had approved its new combination insulin, that it plans to market as Ryzodeg, for the treatment of diabetes.
via Reuters: Health News Read More Here..
No comments:
Post a Comment